{"transactions":[{"id":904677,"issuer":{"id":6950,"kind":"organization","name":"OS Therapies Inc","symbol":"OSTX"},"owners":[{"id":66460,"kind":"person","name":"PETIT ROBERT","position":1,"cik":"0001576077","reported_name":"PETIT ROBERT","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Stock options (right to buy)","published_at":"2026-02-13T16:41:51.000Z","date":"2026-01-22","kind":"grant","planned":false,"acquired":true,"shares":100000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"On January 22, 2026, the reporting person was granted options to purchase 100,000 shares of the issuer's common stock pursuant to the terms and conditions of a stock option award agreement. These options vest in full on the one-year anniversary of the date of grant, provided that the reporting person is serving as an employee of the issuer on such date."}],"balance_after":100000,"derivative":{"exercise_price":1.34,"expiration_date":"2036-01-22","underlying":"Common Stock","underlying_shares":100000},"source":{"system":"sec-edgar","filing":"0001213900-26-016499","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1576077/000121390026016499/ownership.xml","form_type":"4"}},{"id":961845,"issuer":{"id":6950,"kind":"organization","name":"OS Therapies Inc","symbol":"OSTX"},"owners":[{"id":66460,"kind":"person","name":"PETIT ROBERT","position":1,"cik":"0001576077","reported_name":"PETIT ROBERT","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Stock options (right to buy)","published_at":"2025-12-19T18:31:39.000Z","date":"2025-10-21","kind":"grant","planned":false,"acquired":true,"shares":500000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"On October 21, 2025, the reporting person was granted options to purchase 500,000 shares of the issuer's common stock pursuant to the terms and conditions of a stock option award agreement. These options vest in full on the one-year anniversary of the date of grant, provided that the reporting person is serving as an employee of the issuer on such date."}],"balance_after":500000,"derivative":{"exercise_price":1.8,"expiration_date":"2035-10-21","underlying":"Common Stock","underlying_shares":500000},"source":{"system":"sec-edgar","filing":"0001213900-25-123999","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1576077/000121390025123999/ownership.xml","form_type":"4"}},{"id":3771710,"issuer":{"id":93434,"kind":"organization","name":"Ayala Pharmaceuticals, Inc.","symbol":"ADXS"},"owners":[{"id":66460,"kind":"person","name":"PETIT ROBERT","position":1,"cik":"0001576077","reported_name":"PETIT ROBERT","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Option","published_at":"2018-11-07T17:00:24.000Z","date":"2018-11-05","kind":"grant","acquired":true,"shares":150000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F3","text":"This award relates to the annual long term incentive grant awarded by the Compensation Committee following the completion of our 2018 Fiscal Year and is subject to the terms of our 2015 Incentive Plan. The award vests one-third on November 5, 2019, one-third on November 5, 2020, and will be fully vested on November 5, 2021."}],"balance_after":150000,"derivative":{"exercise_price":0.54,"exercise_date":"2019-11-05","expiration_date":"2028-11-05","underlying":"Common Stock","underlying_shares":150000},"source":{"system":"sec-edgar","filing":"0001493152-18-015360","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1100397/000149315218015360/ownership.xml","form_type":"4"}},{"id":3771709,"issuer":{"id":93434,"kind":"organization","name":"Ayala Pharmaceuticals, Inc.","symbol":"ADXS"},"owners":[{"id":66460,"kind":"person","name":"PETIT ROBERT","position":1,"cik":"0001576077","reported_name":"PETIT ROBERT","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Common Stock","published_at":"2018-11-07T17:00:24.000Z","date":"2018-11-05","kind":"sale","acquired":false,"shares":3963,"price":0.58,"value":2298.54,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"In connection with the vesting of 9,534 shares on November 5, 2018, a total of 3,963 of such shares were withheld by the Company in order to satisfy the reporting person's tax withholding obligations. The reporting person had no discretion with respect to such sale, which was conducted automatically in accordance with the issuer's corporate policies."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Reflects the weighted average sale price. The range of prices for such transaction is $0.57 to $0.58. The reporting person effected multiple same-way open market sale transactions on the same day at different prices through a trade order executed by a broker-dealer. The reporting person reported on a single line all such transactions that occurred within a one-dollar price range. The reporting person hereby undertakes to provide upon request by the Securities Exchange Commission staff, the issuer, or a shareholder of the issuer, full information regarding the number of shares sold at each separate price in accordance with the issuer's corporate policies."}],"balance_after":231206,"source":{"system":"sec-edgar","filing":"0001493152-18-015360","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1100397/000149315218015360/ownership.xml","form_type":"4"}},{"id":3774476,"issuer":{"id":93434,"kind":"organization","name":"Ayala Pharmaceuticals, Inc.","symbol":"ADXS"},"owners":[{"id":66460,"kind":"person","name":"PETIT ROBERT","position":1,"cik":"0001576077","reported_name":"PETIT ROBERT","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Common Stock","published_at":"2018-11-05T18:00:14.000Z","date":"2018-11-02","kind":"sale","acquired":false,"shares":8491,"price":0.56,"value":4754.96,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"In connection with the vesting of 28,826 shares on April 2, 2018, a total of 8,491 of such shares were withheld by the Company in order to satisfy the reporting person's tax withholding obligations. The reporting person had no discretion with respect to such sale, which was conducted automatically in accordance with the issuer's corporate policies."}],"balance_after":235169,"source":{"system":"sec-edgar","filing":"0001493152-18-015218","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1100397/000149315218015218/ownership.xml","form_type":"4"}},{"id":3857028,"issuer":{"id":93434,"kind":"organization","name":"Ayala Pharmaceuticals, Inc.","symbol":"ADXS"},"owners":[{"id":66460,"kind":"person","name":"PETIT ROBERT","position":1,"cik":"0001576077","reported_name":"PETIT ROBERT","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Common Stock","published_at":"2018-08-01T16:30:26.000Z","date":"2018-07-31","kind":"grant","acquired":true,"shares":1505,"price":1.46,"value":2197.3,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The reporting person voluntarily purchases restricted stock directly from the Company at market price on the last trading day of the month pursuant to an arrangement that was approved by the Compensation Committee of the Company's Board of Directors in a manner that satisfied Exchange Act Rule 16b-3(d). The Company utilizes the net withholding method for each monthly purchase. The reporting person purchased a gross amount of 1,791 shares of which 286 shares were forfeited to pay withholding taxes associated with the stock issuance."}],"balance_after":243660,"source":{"system":"sec-edgar","filing":"0001493152-18-010799","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1100397/000149315218010799/ownership.xml","form_type":"4"}},{"id":3879105,"issuer":{"id":93434,"kind":"organization","name":"Ayala Pharmaceuticals, Inc.","symbol":"ADXS"},"owners":[{"id":66460,"kind":"person","name":"PETIT ROBERT","position":1,"cik":"0001576077","reported_name":"PETIT ROBERT","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Common Stock","published_at":"2018-07-02T16:30:20.000Z","date":"2018-06-29","kind":"grant","acquired":true,"shares":1516,"price":1.45,"value":2198.2,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"The reporting person voluntarily purchases restricted stock directly from the Company at market price on the last trading day of the month pursuant to an arrangement that was approved by the Compensation Committee of the Company's Board of Directors in a manner that satisfied Exchange Act Rule 16b-3(d). The Company utilizes the net withholding method for each monthly purchase. The reporting person purchased a gross amount of 1,804 shares of which 288 shares were forfeited to pay withholding taxes associated with the stock issuance."}],"balance_after":242155,"source":{"system":"sec-edgar","filing":"0001493152-18-009554","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1100397/000149315218009554/ownership.xml","form_type":"4"}},{"id":3879104,"issuer":{"id":93434,"kind":"organization","name":"Ayala Pharmaceuticals, Inc.","symbol":"ADXS"},"owners":[{"id":66460,"kind":"person","name":"PETIT ROBERT","position":1,"cik":"0001576077","reported_name":"PETIT ROBERT","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Common Stock","published_at":"2018-07-02T16:30:20.000Z","date":"2018-06-18","kind":"grant","acquired":true,"shares":9000,"price":1.72,"value":15480.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents a voluntary at market stock purchase by the reporting person on the open market"}],"balance_after":240639,"source":{"system":"sec-edgar","filing":"0001493152-18-009554","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1100397/000149315218009554/ownership.xml","form_type":"4"}},{"id":3879103,"issuer":{"id":93434,"kind":"organization","name":"Ayala Pharmaceuticals, Inc.","symbol":"ADXS"},"owners":[{"id":66460,"kind":"person","name":"PETIT ROBERT","position":1,"cik":"0001576077","reported_name":"PETIT ROBERT","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Common Stock","published_at":"2018-07-02T16:30:20.000Z","date":"2018-06-12","kind":"grant","acquired":true,"shares":5000,"price":1.84,"value":9200.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents a voluntary at market stock purchase by the reporting person on the open market"}],"balance_after":231639,"source":{"system":"sec-edgar","filing":"0001493152-18-009554","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1100397/000149315218009554/ownership.xml","form_type":"4"}},{"id":3911138,"issuer":{"id":93434,"kind":"organization","name":"Ayala Pharmaceuticals, Inc.","symbol":"ADXS"},"owners":[{"id":66460,"kind":"person","name":"PETIT ROBERT","position":1,"cik":"0001576077","reported_name":"PETIT ROBERT","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Common Stock","published_at":"2018-06-01T16:30:23.000Z","date":"2018-05-31","kind":"grant","acquired":true,"shares":1765,"price":1.82,"value":3212.3,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The reporting person voluntarily purchases restricted stock directly from the Company at market price on the last trading day of the month pursuant to an arrangement that was approved by the Compensation Committee of the Company's Board of Directors in a manner that satisfied Exchange Act Rule 16b-3(d). The Company utilizes the net withholding method for each monthly purchase. The reporting person purchased a gross amount of 2,156 shares of which 391 shares were forfeited to pay withholding taxes associated with the stock issuance."}],"balance_after":226639,"source":{"system":"sec-edgar","filing":"0001493152-18-008133","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1100397/000149315218008133/form4.xml","form_type":"4"}},{"id":3949952,"issuer":{"id":93434,"kind":"organization","name":"Ayala Pharmaceuticals, Inc.","symbol":"ADXS"},"owners":[{"id":66460,"kind":"person","name":"PETIT ROBERT","position":1,"cik":"0001576077","reported_name":"PETIT ROBERT","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Common Stock","published_at":"2018-05-02T16:30:32.000Z","date":"2018-04-30","kind":"grant","acquired":true,"shares":1374,"price":1.6,"value":2198.4,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The reporting person voluntarily purchases restricted stock directly from the Company at market price on the last trading day of the month pursuant to an arrangement that was approved by the Compensation Committee of the Company's Board of Directors in a manner that satisfied Exchange Act Rule 16b-3(d). The Company utilizes the net withholding method for each monthly purchase. The reporting person purchased a gross amount of 1,635 shares of which 261 shares were forfeited to pay withholding taxes associated with the stock issuance."}],"balance_after":224874,"source":{"system":"sec-edgar","filing":"0001493152-18-006133","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1100397/000149315218006133/form4.xml","form_type":"4"}},{"id":3973818,"issuer":{"id":93434,"kind":"organization","name":"Ayala Pharmaceuticals, Inc.","symbol":"ADXS"},"owners":[{"id":66460,"kind":"person","name":"PETIT ROBERT","position":1,"cik":"0001576077","reported_name":"PETIT ROBERT","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Common Stock","published_at":"2018-04-03T16:30:15.000Z","date":"2018-04-02","kind":"sale","acquired":false,"shares":2193,"price":1.62,"value":3552.66,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"In connection with the vesting of 7,773 shares on April 2, 2018, a total of 2,193 of such shares were withheld by the Company in order to satisfy the reporting person's tax withholding obligations. The reporting person had no discretion with respect to such sale, which was conducted automatically in accordance with the issuer's corporate policies."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Reflects the weighted average sale price. The range of prices for such transaction is $1.61 to $1.63. The reporting person effected multiple same-way open market sale transactions on the same day at different prices through a trade order executed by a broker-dealer. The reporting person reported on a single line all such transactions that occurred within a one dollar price range. The reporting person hereby undertakes to provide upon request by the Securities Exchange Commission staff, the issuer, or a shareholder of the issuer, full information regarding the number of shares sold at each separate price in accordance with the issuer's corporate policies."}],"balance_after":223500,"source":{"system":"sec-edgar","filing":"0001493152-18-004693","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1100397/000149315218004693/form4.xml","form_type":"4"}},{"id":3973817,"issuer":{"id":93434,"kind":"organization","name":"Ayala Pharmaceuticals, Inc.","symbol":"ADXS"},"owners":[{"id":66460,"kind":"person","name":"PETIT ROBERT","position":1,"cik":"0001576077","reported_name":"PETIT ROBERT","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Common Stock","published_at":"2018-04-03T16:30:15.000Z","date":"2018-03-29","kind":"grant","acquired":true,"shares":1111,"price":1.69,"value":1877.59,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The reporting person voluntarily purchases restricted stock directly from the Company at market price on the last trading day of the month pursuant to an arrangement that was approved by the Compensation Committee of the Company's Board of Directors in a manner that satisfied Exchange Act Rule 16b-3(d). The Company utilizes the net withholding method for each monthly purchase. The reporting person purchased a gross amount 1,548 shares of which 437 shares were forfeited to pay withholding taxes associated with the stock issuance."}],"balance_after":225693,"source":{"system":"sec-edgar","filing":"0001493152-18-004693","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1100397/000149315218004693/form4.xml","form_type":"4"}},{"id":4024634,"issuer":{"id":93434,"kind":"organization","name":"Ayala Pharmaceuticals, Inc.","symbol":"ADXS"},"owners":[{"id":66460,"kind":"person","name":"PETIT ROBERT","position":1,"cik":"0001576077","reported_name":"PETIT ROBERT","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Common Stock","published_at":"2018-03-01T16:31:31.000Z","date":"2018-02-28","kind":"grant","acquired":true,"shares":1182,"price":1.86,"value":2198.52,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The reporting person voluntarily purchases restricted stock directly from the Company at market price on the last trading day of the month pursuant to an arrangement that was approved by the Compensation Committee of the Company's Board of Directors in a manner that satisfied Exchange Act Rule 16b-3(d). The Company utilizes the net withholding method for each monthly purchase. The reporting person purchased a gross amount 1,406 shares of which 224 shares were forfeited to pay withholding taxes associated with the stock issuance."}],"balance_after":224582,"source":{"system":"sec-edgar","filing":"0001493152-18-002792","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1100397/000149315218002792/form4.xml","form_type":"4"}},{"id":4079721,"issuer":{"id":93434,"kind":"organization","name":"Ayala Pharmaceuticals, Inc.","symbol":"ADXS"},"owners":[{"id":66460,"kind":"person","name":"PETIT ROBERT","position":1,"cik":"0001576077","reported_name":"PETIT ROBERT","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Common Stock","published_at":"2018-02-02T16:30:32.000Z","date":"2018-01-31","kind":"grant","acquired":true,"shares":696,"price":2.96,"value":2060.16,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The reporting person voluntarily purchases restricted stock directly from the Company at market price on the last trading day of the month pursuant to an arrangement that was approved by the Compensation Committee of the Company's Board of Directors in a manner that satisfied Exchange Act Rule 16b-3(d). The Company utilizes the net withholding method for each monthly purchase. The reporting person purchased a gross amount 884 shares of which 188 shares were forfeited to pay withholding taxes associated with the stock issuance."}],"balance_after":223400,"source":{"system":"sec-edgar","filing":"0001493152-18-001417","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1100397/000149315218001417/form4.xml","form_type":"4"}},{"id":4113196,"issuer":{"id":93434,"kind":"organization","name":"Ayala Pharmaceuticals, Inc.","symbol":"ADXS"},"owners":[{"id":66460,"kind":"person","name":"PETIT ROBERT","position":1,"cik":"0001576077","reported_name":"PETIT ROBERT","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Common Stock","published_at":"2018-01-03T18:00:28.000Z","date":"2017-12-29","kind":"grant","acquired":true,"shares":752,"price":2.84,"value":2135.68,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The reporting person voluntarily purchases restricted stock directly from the Company at market price on the last trading day of the month pursuant to an arrangement that was approved by the Compensation Committee of the Company's Board of Directors in a manner that satisfied Exchange Act Rule 16b-3(d). The Company utilizes the net withholding method for each monthly purchase. The reporting person purchased a gross amount 921 shares of which 169 shares were forfeited to pay withholding taxes associated with the stock issuance."}],"balance_after":222704,"source":{"system":"sec-edgar","filing":"0001493152-18-000116","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1100397/000149315218000116/form4.xml","form_type":"4"}},{"id":4144623,"issuer":{"id":93434,"kind":"organization","name":"Ayala Pharmaceuticals, Inc.","symbol":"ADXS"},"owners":[{"id":66460,"kind":"person","name":"PETIT ROBERT","position":1,"cik":"0001576077","reported_name":"PETIT ROBERT","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Common Stock","published_at":"2017-12-04T16:30:30.000Z","date":"2017-11-30","kind":"grant","acquired":true,"shares":1035,"price":2.99,"value":3094.65,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The reporting person voluntarily purchases restricted stock directly from the Company at market price on the last trading day of the month pursuant to an arrangement that was approved by the Compensation Committee of the Company's Board of Directors in a manner that satisfied Exchange Act Rule 16b-3(d). The Company utilizes the net withholding method for each monthly purchase. The reporting person purchased a gross amount of 1,312 shares of which 277 shares were forfeited to pay withholding taxes associated with the stock issuance."}],"balance_after":221952,"source":{"system":"sec-edgar","filing":"0001493152-17-014143","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1100397/000149315217014143/form4.xml","form_type":"4"}},{"id":4171600,"issuer":{"id":93434,"kind":"organization","name":"Ayala Pharmaceuticals, Inc.","symbol":"ADXS"},"owners":[{"id":66460,"kind":"person","name":"PETIT ROBERT","position":1,"cik":"0001576077","reported_name":"PETIT ROBERT","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Option","published_at":"2017-11-06T18:00:28.000Z","date":"2017-11-02","kind":"grant","acquired":true,"shares":100000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F3","text":"This award relates to the annual long term incentive grant awarded by the Compensation Committee following the completion of our 2017 Fiscal Year and is subject to the terms of our 2015 Incentive Plan. The award vests one-third on November 2, 2018, one-third on November 2, 2019, and will be fully vested on November 2, 2020."}],"balance_after":100000,"derivative":{"exercise_price":3.19,"exercise_date":"2018-11-02","expiration_date":"2027-11-02","underlying":"Common stock","underlying_shares":100000},"source":{"system":"sec-edgar","filing":"0001493152-17-012504","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1100397/000149315217012504/form4.xml","form_type":"4"}},{"id":4171599,"issuer":{"id":93434,"kind":"organization","name":"Ayala Pharmaceuticals, Inc.","symbol":"ADXS"},"owners":[{"id":66460,"kind":"person","name":"PETIT ROBERT","position":1,"cik":"0001576077","reported_name":"PETIT ROBERT","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Common Stock","published_at":"2017-11-06T18:00:28.000Z","date":"2017-11-06","kind":"sale","acquired":false,"shares":3723,"price":3.3,"value":12285.9,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"In connection with the vesting of 9,533 shares on November 3, 2017, a total of 3,723 of such shares were withheld by the Company in order to satisfy the reporting person's tax withholding obligations. The reporting person had no discretion with respect to such sale, which was conducted automatically in accordance with the issuer's corporate policies."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Reflects the weighted average sale price. The range of prices for such transaction is $3.30 to $3.31. The reporting person effected multiple same-way open market sale transactions on the same day at different prices through a trade order executed by a broker-dealer. The reporting person reported on a single line all such transactions that occurred within a one dollar price range. The reporting person hereby undertakes to provide upon request by the Securities Exchange Commission staff, the issuer, or a shareholder of the issuer, full information regarding the number of shares sold at each separate price."}],"balance_after":220917,"source":{"system":"sec-edgar","filing":"0001493152-17-012504","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1100397/000149315217012504/form4.xml","form_type":"4"}},{"id":4175069,"issuer":{"id":93434,"kind":"organization","name":"Ayala Pharmaceuticals, Inc.","symbol":"ADXS"},"owners":[{"id":66460,"kind":"person","name":"PETIT ROBERT","position":1,"cik":"0001576077","reported_name":"PETIT ROBERT","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Common Stock","published_at":"2017-11-02T17:54:41.000Z","date":"2017-11-02","kind":"sale","acquired":false,"shares":12625,"price":3.19,"value":40273.75,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"In connection with the vesting of 28,827 shares on November 1, 2017, a total of 12,625 of such shares were withheld by the Company in order to satisfy the reporting person's tax withholding obligations. The reporting person had no discretion with respect to such sale, which was conducted automatically in accordance with the issuer's corporate policies."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Reflects the weighted average sale price. The range of prices for such transaction is $3.15 to $3.21. The reporting person effected multiple same-way open market sale transactions on the same day at different prices through a trade order executed by a broker-dealer. The reporting person reported on a single line all such transactions that occurred within a one dollar price range. The reporting person hereby undertakes to provide upon request by the Securities Exchange Commission staff, the issuer, or a shareholder of the issuer, full information regarding the number of shares sold at each separate price."}],"balance_after":224640,"source":{"system":"sec-edgar","filing":"0001493152-17-012358","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1100397/000149315217012358/form4.xml","form_type":"4"}},{"id":4175068,"issuer":{"id":93434,"kind":"organization","name":"Ayala Pharmaceuticals, Inc.","symbol":"ADXS"},"owners":[{"id":66460,"kind":"person","name":"PETIT ROBERT","position":1,"cik":"0001576077","reported_name":"PETIT ROBERT","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Common Stock","published_at":"2017-11-02T17:54:41.000Z","date":"2017-10-31","kind":"grant","acquired":true,"shares":432,"price":3.4,"value":1468.8,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The reporting person voluntarily purchases restricted stock directly from the Company at market price on the last trading day of the month pursuant to an arrangement that was approved by the Compensation Committee of the Company's Board of Directors in a manner that satisfied Exchange Act Rule 16b-3(d). The Company utilizes the net withholding method for each monthly purchase. The reporting person purchased a gross amount of 769 shares of which 337 shares were forfeited to pay withholding taxes associated with the stock issuance."}],"balance_after":237265,"source":{"system":"sec-edgar","filing":"0001493152-17-012358","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1100397/000149315217012358/form4.xml","form_type":"4"}},{"id":4198024,"issuer":{"id":93434,"kind":"organization","name":"Ayala Pharmaceuticals, Inc.","symbol":"ADXS"},"owners":[{"id":66460,"kind":"person","name":"PETIT ROBERT","position":1,"cik":"0001576077","reported_name":"PETIT ROBERT","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Common Stock","published_at":"2017-10-02T16:30:21.000Z","date":"2017-09-29","kind":"grant","acquired":true,"shares":511,"price":4.18,"value":2135.98,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The reporting person voluntarily purchases restricted stock directly from the Company at market price on the last trading day of the month pursuant to an arrangement that was approved by the Compensation Committee of the Company's Board of Directors in a manner that satisfied Exchange Act Rule 16b-3(d). The Company utilizes the net withholding method for each monthly purchase. The reporting person purchased a gross amount of 626 shares of which 115 shares were forfeited to pay withholding taxes associated with the stock issuance."}],"balance_after":236833,"source":{"system":"sec-edgar","filing":"0001493152-17-011142","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1100397/000149315217011142/form4.xml","form_type":"4"}},{"id":4218167,"issuer":{"id":93434,"kind":"organization","name":"Ayala Pharmaceuticals, Inc.","symbol":"ADXS"},"owners":[{"id":66460,"kind":"person","name":"PETIT ROBERT","position":1,"cik":"0001576077","reported_name":"PETIT ROBERT","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Common Stock","published_at":"2017-09-05T16:30:30.000Z","date":"2017-08-31","kind":"grant","acquired":true,"shares":318,"price":6.81,"value":2165.58,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The reporting person voluntarily purchases restricted stock directly from the Company at market price on the last trading day of the month pursuant to an arrangement that was approved by the Compensation Committee of the Company's Board of Directors in a manner that satisfied Exchange Act Rule 16b-3(d). The Company utilizes the net withholding method for each monthly purchase. The reporting person purchased a gross amount of 384 shares of which 66 shares were forfeited to pay withholding taxes associated with the stock issuance."}],"balance_after":236322,"source":{"system":"sec-edgar","filing":"0001493152-17-010228","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1100397/000149315217010228/form4.xml","form_type":"4"}},{"id":4247529,"issuer":{"id":93434,"kind":"organization","name":"Ayala Pharmaceuticals, Inc.","symbol":"ADXS"},"owners":[{"id":66460,"kind":"person","name":"PETIT ROBERT","position":1,"cik":"0001576077","reported_name":"PETIT ROBERT","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Common Stock","published_at":"2017-08-01T16:30:35.000Z","date":"2017-07-31","kind":"grant","acquired":true,"shares":335,"price":6.47,"value":2167.45,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The reporting person voluntarily purchases restricted stock directly from the Company at market price on the last trading day of the month pursuant to an arrangement that was approved by the Compensation Committee of the Company's Board of Directors in a manner that satisfied Exchange Act Rule 16b-3(d). The Company utilizes the net withholding method for each monthly purchase. The reporting person purchased a gross amount of 405 shares of which 70 shares were forfeited to pay withholding taxes associated with the stock issuance."}],"balance_after":236004,"source":{"system":"sec-edgar","filing":"0001493152-17-008350","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1100397/000149315217008350/form4.xml","form_type":"4"}},{"id":4267774,"issuer":{"id":93434,"kind":"organization","name":"Ayala Pharmaceuticals, Inc.","symbol":"ADXS"},"owners":[{"id":66460,"kind":"person","name":"PETIT ROBERT","position":1,"cik":"0001576077","reported_name":"PETIT ROBERT","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Common Stock","published_at":"2017-07-03T16:31:44.000Z","date":"2017-06-30","kind":"grant","acquired":true,"shares":477,"price":6.49,"value":3095.73,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The reporting person voluntarily purchases restricted stock directly from the Company at market price on the last trading day of the month pursuant to an arrangement that was approved by the Compensation Committee of the Company's Board of Directors in a manner that satisfied Exchange Act Rule 16b-3(d). The Company utilizes the net withholding method for each monthly purchase. The reporting person purchased a gross amount of 604 shares of which 127 shares were forfeited to pay withholding taxes associated with the stock issuance."}],"balance_after":235669,"source":{"system":"sec-edgar","filing":"0001493152-17-007455","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1100397/000149315217007455/form4.xml","form_type":"4"}},{"id":4276287,"issuer":{"id":93434,"kind":"organization","name":"Ayala Pharmaceuticals, Inc.","symbol":"ADXS"},"owners":[{"id":66460,"kind":"person","name":"PETIT ROBERT","position":1,"cik":"0001576077","reported_name":"PETIT ROBERT","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Common Stock","published_at":"2017-06-20T18:30:45.000Z","date":"2017-06-19","kind":"grant","acquired":true,"shares":57199,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"As part of his long-term incentive compensation, the reporting person was previously granted a performance based restricted stock award by the Compensation Committee. The specific terms of performance, which were required to be achieved prior to earning the award, have now been met. These performance terms were (i) the FDA acceptance of the ADXS-NEO IND, and (ii) the opening of a certain pre-defined number of clinical sites for the AIM2CERV study prior to November 1, 2017. The award vests one-third in November 2017, one-third in November 2018, and will be fully vested in November 2019."}],"balance_after":235192,"source":{"system":"sec-edgar","filing":"0001493152-17-006930","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1100397/000149315217006930/form4.xml","form_type":"4"}},{"id":4298335,"issuer":{"id":93434,"kind":"organization","name":"Ayala Pharmaceuticals, Inc.","symbol":"ADXS"},"owners":[{"id":66460,"kind":"person","name":"PETIT ROBERT","position":1,"cik":"0001576077","reported_name":"PETIT ROBERT","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Common Stock","published_at":"2017-06-01T16:30:49.000Z","date":"2017-05-31","kind":"grant","acquired":true,"shares":265,"price":8.07,"value":2138.55,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The reporting voluntarily person purchases restricted stock directly from the Company at market price on the last trading day of the month pursuant to an arrangement that was approved by the Compensation Committee of the Company's Board of Directors in a manner that satisfied Exchange Act Rule 16b-3(d). The Company utilizes the net withholding method for each monthly purchase. The reporting person purchased a gross amount of 324 shares of which 59 shares were forfeited to pay withholding taxes associated with the stock issuance."}],"balance_after":177993,"source":{"system":"sec-edgar","filing":"0001493152-17-006086","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1100397/000149315217006086/form4.xml","form_type":"4"}},{"id":4340606,"issuer":{"id":93434,"kind":"organization","name":"Ayala Pharmaceuticals, Inc.","symbol":"ADXS"},"owners":[{"id":66460,"kind":"person","name":"PETIT ROBERT","position":1,"cik":"0001576077","reported_name":"PETIT ROBERT","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Common Stock","published_at":"2017-05-01T17:31:36.000Z","date":"2017-05-01","kind":"grant","acquired":true,"shares":57881,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"The award vests one-third on November 1, 2017, one-third on November 1, 2018, and will be fully vested on November 1, 2019."}],"balance_after":177728,"source":{"system":"sec-edgar","filing":"0001493152-17-004629","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1100397/000149315217004629/form4.xml","form_type":"4"}},{"id":4340605,"issuer":{"id":93434,"kind":"organization","name":"Ayala Pharmaceuticals, Inc.","symbol":"ADXS"},"owners":[{"id":66460,"kind":"person","name":"PETIT ROBERT","position":1,"cik":"0001576077","reported_name":"PETIT ROBERT","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Common Stock","published_at":"2017-05-01T17:31:36.000Z","date":"2017-04-28","kind":"grant","acquired":true,"shares":250,"price":8.56,"value":2140.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The reporting voluntarily person purchases restricted stock directly from the Company at market price on the last trading day of the month pursuant to an arrangement that was approved by the Compensation Committee of the Company's Board of Directors in a manner that satisfied Exchange Act Rule 16b-3(d). The Company utilizes the net withholding method for each monthly purchase. The reporting person purchased a gross amount of 306 shares of which 56 shares were forfeited to pay withholding taxes associated with the stock issuance."}],"balance_after":119847,"source":{"system":"sec-edgar","filing":"0001493152-17-004629","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1100397/000149315217004629/form4.xml","form_type":"4"}},{"id":4365407,"issuer":{"id":93434,"kind":"organization","name":"Ayala Pharmaceuticals, Inc.","symbol":"ADXS"},"owners":[{"id":66460,"kind":"person","name":"PETIT ROBERT","position":1,"cik":"0001576077","reported_name":"PETIT ROBERT","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Common Stock","published_at":"2017-04-03T16:38:59.000Z","date":"2017-03-31","kind":"sale","acquired":false,"shares":2454,"price":8.24,"value":20220.96,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"In connection with the vesting of 7,773 shares on March 30, 2017, a total of 2,454 of such shares were withheld by the Company in order to satisfy the reporting person's tax withholding obligations. The reporting person had no discretion with respect to such sale, which was conducted automatically in accordance with the issuer's corporate policies."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Reflects the weighted average sale price. The range of prices for such transaction is $8.23 to $8.26. The reporting person effected multiple same-way open market sale transactions on the same day at different prices through a trade order executed by a broker-dealer. The reporting person reported on a single line all such transactions that occurred within a one dollar price range. The reporting person hereby undertakes to provide upon request by the Securities Exchange Commission staff, the issuer, or a shareholder of the issuer, full information regarding the number of shares sold at each separate price."}],"balance_after":119597,"source":{"system":"sec-edgar","filing":"0001493152-17-003407","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1100397/000149315217003407/form4.xml","form_type":"4"}},{"id":4365406,"issuer":{"id":93434,"kind":"organization","name":"Ayala Pharmaceuticals, Inc.","symbol":"ADXS"},"owners":[{"id":66460,"kind":"person","name":"PETIT ROBERT","position":1,"cik":"0001576077","reported_name":"PETIT ROBERT","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Common Stock","published_at":"2017-04-03T16:38:59.000Z","date":"2017-03-31","kind":"grant","acquired":true,"shares":219,"price":8.17,"value":1789.23,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The reporting voluntarily person purchases restricted stock directly from the Company at market price on the last trading day of the month pursuant to an arrangement that was approved by the Compensation Committee of the Company's Board of Directors in a manner that satisfied Exchange Act Rule 16b-3(d). The Company utilizes the net withholding method for each monthly purchase. The reporting person purchased a gross amount of 320 shares of which 101 shares were forfeited to pay withholding taxes associated with the stock issuance."}],"balance_after":122051,"source":{"system":"sec-edgar","filing":"0001493152-17-003407","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1100397/000149315217003407/form4.xml","form_type":"4"}},{"id":4414631,"issuer":{"id":93434,"kind":"organization","name":"Ayala Pharmaceuticals, Inc.","symbol":"ADXS"},"owners":[{"id":66460,"kind":"person","name":"PETIT ROBERT","position":1,"cik":"0001576077","reported_name":"PETIT ROBERT","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Common Stock","published_at":"2017-03-01T16:30:45.000Z","date":"2017-02-28","kind":"tax_withholding","acquired":false,"shares":52,"price":8.79,"value":457.08,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Represents shares forfeited by the reporting person in order to pay withholding taxes associated with the stock issuance."}],"balance_after":121832,"source":{"system":"sec-edgar","filing":"0001493152-17-002030","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1100397/000149315217002030/form4.xml","form_type":"4"}},{"id":4414630,"issuer":{"id":93434,"kind":"organization","name":"Ayala Pharmaceuticals, Inc.","symbol":"ADXS"},"owners":[{"id":66460,"kind":"person","name":"PETIT ROBERT","position":1,"cik":"0001576077","reported_name":"PETIT ROBERT","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Common Stock","published_at":"2017-03-01T16:30:45.000Z","date":"2017-02-28","kind":"grant","acquired":true,"shares":298,"price":8.79,"value":2619.42,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The reporting person purchases restricted stock directly from the Company at market price on the last trading day of the month pursuant to an arrangement that was approved by the Compensation Committee of the Company's Board of Directors in a manner that satisfied Exchange Act Rule 16b-3(d)."}],"balance_after":121884,"source":{"system":"sec-edgar","filing":"0001493152-17-002030","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1100397/000149315217002030/form4.xml","form_type":"4"}},{"id":4471466,"issuer":{"id":93434,"kind":"organization","name":"Ayala Pharmaceuticals, Inc.","symbol":"ADXS"},"owners":[{"id":66460,"kind":"person","name":"PETIT ROBERT","position":1,"cik":"0001576077","reported_name":"PETIT ROBERT","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Common Stock","published_at":"2017-02-02T16:31:01.000Z","date":"2017-01-31","kind":"tax_withholding","acquired":false,"shares":48,"price":8.96,"value":430.08,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Represents shares forfeited by the reporting person in order to pay withholding taxes associated with the stock issuance."}],"balance_after":121586,"source":{"system":"sec-edgar","filing":"0001493152-17-001038","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1100397/000149315217001038/form4.xml","form_type":"4"}},{"id":4471465,"issuer":{"id":93434,"kind":"organization","name":"Ayala Pharmaceuticals, Inc.","symbol":"ADXS"},"owners":[{"id":66460,"kind":"person","name":"PETIT ROBERT","position":1,"cik":"0001576077","reported_name":"PETIT ROBERT","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Common Stock","published_at":"2017-02-02T16:31:01.000Z","date":"2017-01-31","kind":"grant","acquired":true,"shares":282,"price":8.96,"value":2526.72,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The reporting person purchases restricted stock directly from the Company at market price on the last trading day of the month pursuant to an arrangement that was approved by the Compensation Committee of the Company's Board of Directors in a manner that satisfied Exchange Act Rule 16b-3(d)."}],"balance_after":121634,"source":{"system":"sec-edgar","filing":"0001493152-17-001038","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1100397/000149315217001038/form4.xml","form_type":"4"}},{"id":4508185,"issuer":{"id":93434,"kind":"organization","name":"Ayala Pharmaceuticals, Inc.","symbol":"ADXS"},"owners":[{"id":66460,"kind":"person","name":"PETIT ROBERT","position":1,"cik":"0001576077","reported_name":"PETIT ROBERT","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Common Stock","published_at":"2017-01-03T17:28:43.000Z","date":"2016-12-30","kind":"tax_withholding","acquired":false,"shares":93,"price":7.16,"value":665.88,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Represents shares forfeited by the reporting person in order to pay withholding taxes associated with the stock issuance."}],"balance_after":121352,"source":{"system":"sec-edgar","filing":"0001493152-17-000065","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1100397/000149315217000065/form4.xml","form_type":"4"}},{"id":4508184,"issuer":{"id":93434,"kind":"organization","name":"Ayala Pharmaceuticals, Inc.","symbol":"ADXS"},"owners":[{"id":66460,"kind":"person","name":"PETIT ROBERT","position":1,"cik":"0001576077","reported_name":"PETIT ROBERT","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Common Stock","published_at":"2017-01-03T17:28:43.000Z","date":"2016-12-30","kind":"grant","acquired":true,"shares":476,"price":7.16,"value":3408.16,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The reporting person purchases restricted stock directly from the Company at market price on the last trading day of the month pursuant to an arrangement that was approved by the Compensation Committee of the Company's Board of Directors in a manner that satisfied Exchange Act Rule 16b-3(d)."}],"balance_after":121445,"source":{"system":"sec-edgar","filing":"0001493152-17-000065","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1100397/000149315217000065/form4.xml","form_type":"4"}},{"id":4537405,"issuer":{"id":93434,"kind":"organization","name":"Ayala Pharmaceuticals, Inc.","symbol":"ADXS"},"owners":[{"id":66460,"kind":"person","name":"PETIT ROBERT","position":1,"cik":"0001576077","reported_name":"PETIT ROBERT","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Common Stock","published_at":"2016-12-01T16:34:26.000Z","date":"2016-11-30","kind":"tax_withholding","acquired":false,"shares":49,"price":8.31,"value":407.19,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Represents shares forfeited by the reporting person in order to pay withholding taxes associated with the stock issuance."}],"balance_after":120969,"source":{"system":"sec-edgar","filing":"0001493152-16-015591","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1100397/000149315216015591/form4.xml","form_type":"4"}},{"id":4537404,"issuer":{"id":93434,"kind":"organization","name":"Ayala Pharmaceuticals, Inc.","symbol":"ADXS"},"owners":[{"id":66460,"kind":"person","name":"PETIT ROBERT","position":1,"cik":"0001576077","reported_name":"PETIT ROBERT","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Common Stock","published_at":"2016-12-01T16:34:26.000Z","date":"2016-11-30","kind":"grant","acquired":true,"shares":274,"price":8.31,"value":2276.94,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The reporting person purchases restricted stock directly from the Company at market price on the last trading day of the month pursuant to an arrangement that was approved by the Compensation Committee of the Company's Board of Directors in a manner that satisfied Exchange Act Rule 16b-3(d)."}],"balance_after":121018,"source":{"system":"sec-edgar","filing":"0001493152-16-015591","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1100397/000149315216015591/form4.xml","form_type":"4"}},{"id":4565517,"issuer":{"id":93434,"kind":"organization","name":"Ayala Pharmaceuticals, Inc.","symbol":"ADXS"},"owners":[{"id":66460,"kind":"person","name":"PETIT ROBERT","position":1,"cik":"0001576077","reported_name":"PETIT ROBERT","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Option","published_at":"2016-11-07T16:30:27.000Z","date":"2016-11-03","kind":"grant","acquired":true,"shares":68906,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"This award relates to the annual long term incentive grant awarded by the Compensation Committee following the completion of our 2016 Fiscal Year and is subject to the terms of our 2015 Incentive Plan. The award vests one-third on November 3, 2017, one-third on November 3, 2018, and will be fully vested on November 3, 2019."}],"balance_after":68906,"derivative":{"exercise_price":7.71,"exercise_date":"2017-11-03","expiration_date":"2026-11-03","underlying":"Common Stock","underlying_shares":68906},"source":{"system":"sec-edgar","filing":"0001493152-16-014573","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1100397/000149315216014573/form4.xml","form_type":"4"}},{"id":4569599,"issuer":{"id":93434,"kind":"organization","name":"Ayala Pharmaceuticals, Inc.","symbol":"ADXS"},"owners":[{"id":66460,"kind":"person","name":"PETIT ROBERT","position":1,"cik":"0001576077","reported_name":"PETIT ROBERT","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Common Stock","published_at":"2016-11-02T16:41:18.000Z","date":"2016-11-02","kind":"sale","acquired":false,"shares":2797,"price":8.32,"value":23271.04,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F3","text":"In connection with the vesting of 6,667 shares on October 31, 2016, a total of 2,797 of such shares were withheld by the Company in order to satisfy the reporting person's tax withholding obligations. The reporting person had no discretion with respect to such sale, which was conducted automatically in accordance with the issuer's corporate policies."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"Reflects the weighted average sale price. The range of prices for such transaction is $8.19 to $8.46. The reporting person effected multiple same-way open market sale transactions on the same day at different prices through a trade order executed by a broker-dealer. The reporting person reported on a single line all such transactions that occurred within a one dollar price range. The reporting person hereby undertakes to provide upon request by the Securities Exchange Commission staff, the issuer, or a shareholder of the issuer, full information regarding the number of shares sold at each separate price."}],"balance_after":120744,"source":{"system":"sec-edgar","filing":"0001493152-16-014445","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1100397/000149315216014445/form4.xml","form_type":"4"}},{"id":4569598,"issuer":{"id":93434,"kind":"organization","name":"Ayala Pharmaceuticals, Inc.","symbol":"ADXS"},"owners":[{"id":66460,"kind":"person","name":"PETIT ROBERT","position":1,"cik":"0001576077","reported_name":"PETIT ROBERT","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Common Stock","published_at":"2016-11-02T16:41:18.000Z","date":"2016-10-31","kind":"tax_withholding","acquired":false,"shares":118,"price":8.09,"value":954.62,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Represents shares forfeited by the reporting person in order to pay withholding taxes associated with the stock issuance."}],"balance_after":123541,"source":{"system":"sec-edgar","filing":"0001493152-16-014445","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1100397/000149315216014445/form4.xml","form_type":"4"}},{"id":4569597,"issuer":{"id":93434,"kind":"organization","name":"Ayala Pharmaceuticals, Inc.","symbol":"ADXS"},"owners":[{"id":66460,"kind":"person","name":"PETIT ROBERT","position":1,"cik":"0001576077","reported_name":"PETIT ROBERT","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Common Stock","published_at":"2016-11-02T16:41:18.000Z","date":"2016-10-31","kind":"grant","acquired":true,"shares":281,"price":8.09,"value":2273.29,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The reporting person purchases restricted stock directly from the Company at market price on the last trading day of the month pursuant to an arrangement that was approved by the Compensation Committee of the Company's Board of Directors in a manner that satisfied Exchange Act Rule 16b-3(d)."}],"balance_after":123659,"source":{"system":"sec-edgar","filing":"0001493152-16-014445","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1100397/000149315216014445/form4.xml","form_type":"4"}},{"id":4587641,"issuer":{"id":93434,"kind":"organization","name":"Ayala Pharmaceuticals, Inc.","symbol":"ADXS"},"owners":[{"id":66460,"kind":"person","name":"PETIT ROBERT","position":1,"cik":"0001576077","reported_name":"PETIT ROBERT","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Common Stock","published_at":"2016-10-04T18:24:54.000Z","date":"2016-09-30","kind":"tax_withholding","acquired":false,"shares":32,"price":10.69,"value":342.08,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Represents shares forfeited by the reporting person in order to pay withholding taxes associated with the stock issuance."}],"balance_after":123378,"source":{"system":"sec-edgar","filing":"0001493152-16-013844","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1100397/000149315216013844/form4.xml","form_type":"4"}},{"id":4587640,"issuer":{"id":93434,"kind":"organization","name":"Ayala Pharmaceuticals, Inc.","symbol":"ADXS"},"owners":[{"id":66460,"kind":"person","name":"PETIT ROBERT","position":1,"cik":"0001576077","reported_name":"PETIT ROBERT","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Common Stock","published_at":"2016-10-04T18:24:54.000Z","date":"2016-09-30","kind":"grant","acquired":true,"shares":213,"price":10.69,"value":2276.97,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The reporting person purchases restricted stock directly from the Company at market price on the last trading day of the month pursuant to an arrangement that was approved by the Compensation Committee of the Company's Board of Directors in a manner that satisfied Exchange Act Rule 16b-3(d)."}],"balance_after":123410,"source":{"system":"sec-edgar","filing":"0001493152-16-013844","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1100397/000149315216013844/form4.xml","form_type":"4"}}]}